Molecular targeting therapies for neuroblastoma: Progress and challenges.
Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R.
Zafar A, et al.
Med Res Rev. 2021 Mar;41(2):961-1021. doi: 10.1002/med.21750. Epub 2020 Nov 6.
Med Res Rev. 2021.
PMID: 33155698
Free PMC article.
Review.
Neuroblastoma is the most common pediatric solid tumor, and accounts for ~15% of childhood cancer-related mortality. Neuroblastomas exhibit genetic, morphological and clinical heterogeneity, which limits the efficacy of existing treatment modalities. ...
Neuroblastoma is the most common pediatric solid tumor, and accounts for ~15% of childhood cancer-related mortality. Neuroblastomas e …